Date: October 11, 2022
Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST)
Antimicrobial resistance (AMR) is one of the leading health threats facing humankind. With AMR, microbes can withstand the effects of antimicrobial medicines, even when the infecting organisms have previously been killed by treatment. In order to develop novel, more effective therapies, researchers need a better understanding of the mechanisms of resistance, the genetic structure and phenotypic diversity of the organisms causing the disease, and the host immune response to the infecting agent. In this webinar, we will explore how technologies such as high-content imaging, machine learning, in vivo mouse models, and fluorescent bacterial and in vivo imaging support the development of novel antimicrobials, immunotherapies, and vaccines against highly resistant Klebsiella, Salmonella, and Staphylococcus aureus.
- Identifying novel anti-microbial therapies with bioluminescent bacteria
- Utilizing Fluorescent reporter mice to visualize vaccine response kinetics
- Uncover novel immune mechanisms in skin inflammation with In vivo imaging
- Use high-content imaging to phenotype the effects of antimicrobial exposure on individual bacterial cells
- Generate greater throughput and modernize bacteriology research
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.